Concepts (251)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prions | 22 | 2019 | 54 | 3.230 |
Why?
|
| Gerstmann-Straussler-Scheinker Disease | 11 | 2019 | 13 | 2.210 |
Why?
|
| Prion Diseases | 14 | 2019 | 32 | 1.940 |
Why?
|
| PrPSc Proteins | 12 | 2021 | 22 | 1.930 |
Why?
|
| PrPC Proteins | 9 | 2021 | 13 | 1.930 |
Why?
|
| Plaque, Amyloid | 4 | 2019 | 56 | 1.840 |
Why?
|
| Alzheimer Disease | 7 | 2019 | 470 | 1.160 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 10 | 2010 | 25 | 0.850 |
Why?
|
| Disease Models, Animal | 7 | 2021 | 2232 | 0.770 |
Why?
|
| Mice, Transgenic | 14 | 2021 | 1540 | 0.720 |
Why?
|
| Benzodioxoles | 1 | 2019 | 16 | 0.700 |
Why?
|
| Pyrazoles | 1 | 2019 | 153 | 0.640 |
Why?
|
| Amyloid beta-Peptides | 1 | 2019 | 203 | 0.630 |
Why?
|
| Brain | 12 | 2012 | 2216 | 0.530 |
Why?
|
| Parahippocampal Gyrus | 1 | 2013 | 3 | 0.480 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 31 | 0.480 |
Why?
|
| Mice | 19 | 2021 | 11352 | 0.440 |
Why?
|
| Cognitive Dysfunction | 1 | 2013 | 132 | 0.410 |
Why?
|
| Sirolimus | 1 | 2012 | 169 | 0.400 |
Why?
|
| Animals | 29 | 2021 | 26581 | 0.380 |
Why?
|
| Cytosol | 2 | 2010 | 189 | 0.380 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2010 | 94 | 0.350 |
Why?
|
| Prion Proteins | 6 | 2018 | 10 | 0.350 |
Why?
|
| Mutation, Missense | 1 | 2009 | 276 | 0.310 |
Why?
|
| Wasting Disease, Chronic | 2 | 2021 | 2 | 0.310 |
Why?
|
| Deer | 2 | 2021 | 5 | 0.310 |
Why?
|
| Phenotype | 9 | 2018 | 2377 | 0.300 |
Why?
|
| Zoonoses | 2 | 2021 | 26 | 0.300 |
Why?
|
| Clonidine | 5 | 1989 | 37 | 0.270 |
Why?
|
| Dementia | 4 | 2010 | 187 | 0.260 |
Why?
|
| Aphasia, Primary Progressive | 1 | 2005 | 86 | 0.250 |
Why?
|
| Endopeptidase K | 2 | 2019 | 12 | 0.240 |
Why?
|
| Sclerosis | 1 | 2003 | 28 | 0.240 |
Why?
|
| Point Mutation | 2 | 2001 | 246 | 0.230 |
Why?
|
| Ataxia | 2 | 2009 | 37 | 0.220 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2005 | 182 | 0.220 |
Why?
|
| Gene Expression | 2 | 2006 | 1284 | 0.220 |
Why?
|
| Equipment Contamination | 1 | 2002 | 22 | 0.220 |
Why?
|
| Surgical Instruments | 1 | 2002 | 57 | 0.210 |
Why?
|
| Iatrogenic Disease | 1 | 2002 | 69 | 0.210 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2003 | 122 | 0.210 |
Why?
|
| Amyloid | 2 | 2000 | 85 | 0.210 |
Why?
|
| Hippocampus | 2 | 2003 | 442 | 0.210 |
Why?
|
| Protein Precursors | 2 | 2000 | 143 | 0.210 |
Why?
|
| Neurosurgical Procedures | 1 | 2002 | 213 | 0.180 |
Why?
|
| Disease Progression | 4 | 2018 | 1531 | 0.180 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2020 | 81 | 0.180 |
Why?
|
| Family Health | 1 | 2000 | 162 | 0.180 |
Why?
|
| Receptors, Opioid | 2 | 1989 | 24 | 0.160 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2020 | 261 | 0.160 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2018 | 66 | 0.160 |
Why?
|
| Genotype | 4 | 2010 | 1850 | 0.160 |
Why?
|
| Male | 21 | 2020 | 40956 | 0.150 |
Why?
|
| Cell Line, Tumor | 4 | 2008 | 2426 | 0.150 |
Why?
|
| Humans | 30 | 2021 | 86601 | 0.150 |
Why?
|
| Mutation | 7 | 2010 | 3967 | 0.150 |
Why?
|
| Rats, Inbred SHR | 5 | 1989 | 29 | 0.150 |
Why?
|
| Rats, Inbred Strains | 5 | 1989 | 312 | 0.150 |
Why?
|
| tau Proteins | 2 | 2011 | 62 | 0.140 |
Why?
|
| Biological Assay | 1 | 2016 | 78 | 0.140 |
Why?
|
| Inclusion Bodies | 2 | 2012 | 34 | 0.130 |
Why?
|
| Neuroblastoma | 3 | 2008 | 374 | 0.130 |
Why?
|
| Thalamus | 2 | 2010 | 132 | 0.130 |
Why?
|
| Endorphins | 3 | 1989 | 13 | 0.130 |
Why?
|
| Protein Isoforms | 2 | 2010 | 270 | 0.130 |
Why?
|
| Fasciculation | 1 | 1994 | 1 | 0.120 |
Why?
|
| Blotting, Western | 2 | 2009 | 782 | 0.120 |
Why?
|
| Abducens Nerve | 1 | 1994 | 14 | 0.120 |
Why?
|
| Lyme Disease | 1 | 1994 | 8 | 0.120 |
Why?
|
| Ophthalmoplegia | 1 | 1994 | 11 | 0.120 |
Why?
|
| Female | 11 | 2019 | 44507 | 0.120 |
Why?
|
| Autophagy | 1 | 2016 | 149 | 0.120 |
Why?
|
| Protein Conformation | 3 | 2010 | 881 | 0.120 |
Why?
|
| Spinal Curvatures | 1 | 2013 | 7 | 0.120 |
Why?
|
| Aged | 12 | 2020 | 18402 | 0.120 |
Why?
|
| Aged, 80 and over | 6 | 2013 | 6501 | 0.110 |
Why?
|
| Peptide Hydrolases | 2 | 2010 | 100 | 0.110 |
Why?
|
| Time Factors | 3 | 2012 | 5209 | 0.110 |
Why?
|
| Amyloid Neuropathies, Familial | 1 | 2013 | 25 | 0.110 |
Why?
|
| Blood Pressure | 4 | 1987 | 1143 | 0.110 |
Why?
|
| Muscular Diseases | 1 | 2013 | 63 | 0.110 |
Why?
|
| Neurofibrillary Tangles | 2 | 2011 | 45 | 0.110 |
Why?
|
| Biomarkers | 1 | 2019 | 1718 | 0.110 |
Why?
|
| Base Sequence | 4 | 2005 | 2330 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 860 | 0.110 |
Why?
|
| Tunicamycin | 1 | 2012 | 12 | 0.110 |
Why?
|
| Random Allocation | 1 | 2012 | 332 | 0.100 |
Why?
|
| Cardiovascular Physiological Phenomena | 2 | 1989 | 36 | 0.100 |
Why?
|
| Analgesia | 2 | 1989 | 57 | 0.100 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2013 | 294 | 0.100 |
Why?
|
| Codon, Nonsense | 1 | 2011 | 41 | 0.100 |
Why?
|
| Kuru | 1 | 2010 | 3 | 0.100 |
Why?
|
| Insomnia, Fatal Familial | 1 | 2010 | 3 | 0.100 |
Why?
|
| Protein Folding | 2 | 2010 | 280 | 0.100 |
Why?
|
| Injections, Intraventricular | 2 | 2006 | 19 | 0.090 |
Why?
|
| Brain Stem | 1 | 2010 | 165 | 0.090 |
Why?
|
| Benzothiazoles | 1 | 2009 | 17 | 0.090 |
Why?
|
| Hypertension | 3 | 1987 | 1141 | 0.090 |
Why?
|
| Heart Rate | 3 | 1987 | 492 | 0.090 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 1989 | 16 | 0.090 |
Why?
|
| Fungal Proteins | 1 | 2010 | 141 | 0.090 |
Why?
|
| Bradycardia | 1 | 1989 | 39 | 0.080 |
Why?
|
| Protein Structure, Secondary | 1 | 2010 | 330 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2013 | 663 | 0.080 |
Why?
|
| Mice, Knockout | 2 | 2012 | 1924 | 0.080 |
Why?
|
| Thiazoles | 1 | 2009 | 131 | 0.080 |
Why?
|
| Cerebellum | 1 | 2010 | 247 | 0.080 |
Why?
|
| Transfection | 2 | 2008 | 896 | 0.080 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1987 | 16 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 1565 | 0.080 |
Why?
|
| Protein Binding | 2 | 2010 | 1456 | 0.080 |
Why?
|
| Leupeptins | 1 | 2006 | 21 | 0.070 |
Why?
|
| DNA Mutational Analysis | 3 | 2010 | 526 | 0.070 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2006 | 53 | 0.070 |
Why?
|
| Rats | 7 | 1989 | 3990 | 0.070 |
Why?
|
| Circular Dichroism | 1 | 2006 | 117 | 0.070 |
Why?
|
| Cerebral Ventricles | 1 | 1986 | 76 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 316 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 1208 | 0.070 |
Why?
|
| Perfusion | 1 | 1986 | 203 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 268 | 0.070 |
Why?
|
| Amino Acid Substitution | 2 | 2003 | 339 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2008 | 2270 | 0.070 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 55 | 0.070 |
Why?
|
| Yeasts | 1 | 2005 | 49 | 0.070 |
Why?
|
| Neurons | 3 | 2018 | 1546 | 0.060 |
Why?
|
| Middle Aged | 8 | 2011 | 25017 | 0.060 |
Why?
|
| Species Specificity | 5 | 2011 | 678 | 0.060 |
Why?
|
| Protein Interaction Mapping | 1 | 2005 | 82 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 1801 | 0.060 |
Why?
|
| Heterozygote | 1 | 2005 | 365 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 1998 | 3030 | 0.060 |
Why?
|
| Sequence Deletion | 1 | 2005 | 205 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 3092 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 646 | 0.060 |
Why?
|
| Tryptamines | 1 | 1983 | 1 | 0.060 |
Why?
|
| Histological Techniques | 1 | 1983 | 35 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2010 | 1351 | 0.060 |
Why?
|
| Catecholamines | 1 | 1983 | 88 | 0.060 |
Why?
|
| Risk Factors | 2 | 2011 | 5416 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2020 | 3352 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 1986 | 521 | 0.050 |
Why?
|
| Prevalence | 1 | 2005 | 1239 | 0.050 |
Why?
|
| Fatal Outcome | 2 | 1999 | 293 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2005 | 1804 | 0.050 |
Why?
|
| Naloxone | 3 | 1989 | 59 | 0.040 |
Why?
|
| Image Enhancement | 1 | 1983 | 563 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2003 | 819 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1999 | 54 | 0.040 |
Why?
|
| Genetic Counseling | 1 | 2000 | 100 | 0.040 |
Why?
|
| Tomography, Emission-Computed | 1 | 1999 | 103 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 1999 | 121 | 0.040 |
Why?
|
| Adult | 6 | 2011 | 25640 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2003 | 557 | 0.040 |
Why?
|
| Blood Component Transfusion | 1 | 1998 | 13 | 0.040 |
Why?
|
| Genetic Markers | 1 | 1999 | 476 | 0.040 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 1998 | 12 | 0.040 |
Why?
|
| Neuroglia | 1 | 2018 | 104 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 1753 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 1997 | 64 | 0.040 |
Why?
|
| Myoclonus | 1 | 1997 | 15 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1998 | 135 | 0.040 |
Why?
|
| Neurodegenerative Diseases | 1 | 1998 | 44 | 0.040 |
Why?
|
| Biopsy | 1 | 2020 | 1161 | 0.040 |
Why?
|
| Hand | 1 | 1997 | 130 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2020 | 707 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 1998 | 250 | 0.040 |
Why?
|
| Jews | 1 | 1995 | 42 | 0.030 |
Why?
|
| Genetic Testing | 2 | 2010 | 535 | 0.030 |
Why?
|
| Pedigree | 1 | 1996 | 966 | 0.030 |
Why?
|
| Cricetinae | 3 | 1998 | 560 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 878 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 927 | 0.030 |
Why?
|
| Age of Onset | 2 | 2008 | 310 | 0.030 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2012 | 8 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2012 | 135 | 0.030 |
Why?
|
| Apoptosis | 1 | 2018 | 1683 | 0.030 |
Why?
|
| Cardiovascular System | 2 | 1989 | 71 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2016 | 1078 | 0.020 |
Why?
|
| Tyrosine | 1 | 2011 | 133 | 0.020 |
Why?
|
| Rats, Inbred WKY | 2 | 1987 | 31 | 0.020 |
Why?
|
| Memory Disorders | 1 | 2011 | 69 | 0.020 |
Why?
|
| Glutamine | 1 | 2011 | 76 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 510 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 411 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 2436 | 0.020 |
Why?
|
| DNA | 1 | 1995 | 1294 | 0.020 |
Why?
|
| Enkephalin, Leucine | 1 | 1989 | 6 | 0.020 |
Why?
|
| Amyloidosis | 1 | 2011 | 115 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2011 | 989 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2011 | 158 | 0.020 |
Why?
|
| Receptors, Opioid, mu | 1 | 1989 | 45 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2011 | 502 | 0.020 |
Why?
|
| Protein Denaturation | 1 | 2008 | 106 | 0.020 |
Why?
|
| Alanine | 1 | 2008 | 85 | 0.020 |
Why?
|
| Nerve Degeneration | 1 | 2008 | 83 | 0.020 |
Why?
|
| Epitopes | 1 | 2008 | 255 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 1989 | 347 | 0.020 |
Why?
|
| Prazosin | 1 | 1987 | 9 | 0.020 |
Why?
|
| beta-Endorphin | 1 | 1987 | 11 | 0.020 |
Why?
|
| Yohimbine | 1 | 1987 | 7 | 0.020 |
Why?
|
| Memory, Short-Term | 1 | 2011 | 220 | 0.020 |
Why?
|
| Naltrexone | 1 | 1989 | 135 | 0.020 |
Why?
|
| Hypothalamus | 1 | 1987 | 79 | 0.020 |
Why?
|
| Mesocricetus | 2 | 1998 | 107 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 746 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2008 | 679 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1986 | 104 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1986 | 244 | 0.020 |
Why?
|
| Tachyphylaxis | 1 | 1985 | 14 | 0.020 |
Why?
|
| Genetic Linkage | 2 | 1999 | 623 | 0.020 |
Why?
|
| Catheters, Indwelling | 1 | 1986 | 110 | 0.020 |
Why?
|
| Drug Tolerance | 1 | 1985 | 63 | 0.020 |
Why?
|
| Prognosis | 1 | 2013 | 3674 | 0.020 |
Why?
|
| Equipment Design | 1 | 1986 | 406 | 0.020 |
Why?
|
| Peptides | 1 | 2008 | 639 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1989 | 1961 | 0.020 |
Why?
|
| Freeze Drying | 1 | 1983 | 14 | 0.010 |
Why?
|
| Incidence | 1 | 2008 | 1576 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1983 | 171 | 0.010 |
Why?
|
| Fluorescence | 1 | 1983 | 102 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 279 | 0.010 |
Why?
|
| Primates | 1 | 1983 | 151 | 0.010 |
Why?
|
| Apolipoprotein C-I | 1 | 1999 | 2 | 0.010 |
Why?
|
| Apolipoproteins C | 1 | 1999 | 5 | 0.010 |
Why?
|
| Lod Score | 1 | 1999 | 152 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1999 | 110 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 1999 | 129 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 5974 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 1999 | 132 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1998 | 130 | 0.010 |
Why?
|
| Perceptual Disorders | 1 | 1997 | 12 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1998 | 117 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 1998 | 82 | 0.010 |
Why?
|
| Endopeptidases | 1 | 1998 | 116 | 0.010 |
Why?
|
| Atrophy | 1 | 1997 | 117 | 0.010 |
Why?
|
| Protons | 1 | 1997 | 98 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1997 | 318 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 1998 | 228 | 0.010 |
Why?
|
| Libya | 1 | 1995 | 3 | 0.010 |
Why?
|
| Life Tables | 1 | 1995 | 48 | 0.010 |
Why?
|
| Genetic Carrier Screening | 1 | 1995 | 60 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1995 | 177 | 0.010 |
Why?
|
| Transgenes | 1 | 1995 | 180 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 1995 | 111 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1995 | 193 | 0.010 |
Why?
|
| Probability | 1 | 1995 | 355 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 2062 | 0.010 |
Why?
|
| Age Factors | 1 | 1995 | 1849 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1998 | 2207 | 0.000 |
Why?
|
| Adolescent | 1 | 1995 | 8979 | 0.000 |
Why?
|